Wall Street expects a year-over-year increase in earnings on higher revenues when Sage Therapeutics, Inc. (SAGE) reports results for the quarter ended September 2024. While this widely-known consensus ...
CAMBRIDGE, Mass. - Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company, has announced a significant reorganization of its operations, which includes a workforce reduction impacting ...